The receptor status between in primary tumor and in its involved regional node referring to estrogen receptor and epidermal growth factor receptor in human breast cancer: preliminary report
Mori, T.; Morimoto, T.; Komaki, K.; Monden, Y.
Nihon Geka Gakkai Zasshi 90(10): 1820
1989
ISSN/ISBN: 0301-4894 PMID: 2594014 Document Number: 332003
Document emailed within 1 workday
Related Documents
Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2010: Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy Zhonghua Zhong Liu Za Zhi 32(7): 520-525Olapade-Olaopa, E.O.; Moscatello, D.K.; MacKay, E.H.; Sandhu, D.P.S.; Terry, T.R.; Wong, A.J.; Habib, F.K. 2004: Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer African Journal of Medicine and Medical Sciences 33(3): 245-253
Wang, L.; Zhang, X.; Wang, Z-Yi. 2010: The Wilms' tumor suppressor WT1 regulates expression of members of the epidermal growth factor receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance Anticancer Research 30(9): 3637-3642
Gillies, S.D.; Wesolowski, J.S.; Lo, K.M. 1991: Targeting human cytotoxic T lymphocytes to kill heterologous epidermal growth factor receptor-bearing tumor cells. Tumor-infiltrating lymphocyte/hormone receptor/recombinant antibody Journal of Immunology 146(3): 1067-1071
Ying, J.-m.; Guo, L.; Liu, X.-y.; Qiu, T.; Lü, N. 2010: Automated silver-enhanced in situ hybridization detection assay for human epidermal growth factor receptor 2 gene status determination in breast cancer Zhonghua Yi Xue Za Zhi 90(24): 1674-1677
Caldarola, L.; Calderini, P.; Volterrani, P.; Di Carlo, F.; Gaglia, P. 1983: The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancer Italian Journal of Surgical Sciences 13(3): 179-185
Robertson, K.W.; Reeves, J.R.; Smith, G.; Keith, W.N.; Ozanne, B.W.; Cooke, T.G.; Stanton, P.D. 1996: Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer Cancer Research 56(16): 3823-3830
Fan, Z.; Masui, H.; Altas, I.; Mendelsohn, J. 1993: Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies Cancer Research 53(18): 4322-4328
Castles, C.G.; Fuqua, S.A.; Klotz, D.M.; Hill, S.M. 1993: Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line Cancer Research 53(24): 5934-5939
Horwitz, K.B.; McGuire, W.L. 1978: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor Journal of Biological Chemistry 253(7): 2223-2228
Ferguson, A.T.; Lapidus, R.G.; Baylin, S.B.; Davidson, N.E. 1995: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Research 55(11): 2279-2283
Gauthier, M.L.; Torretto, C.; Ly, J.; Francescutti, V.; O'Day, D.H. 2003: Protein kinase Calpha negatively regulates cell spreading and motility in MDA-MB-231 human breast cancer cells downstream of epidermal growth factor receptor Biochemical and Biophysical Research Communications 307(4): 839-846
Wu, X.; Peng, L. 1997: Expression of epidermal growth factor and its receptor in human primary hepatocellular carcinoma Hunan Yi Ke da Xue Xue Bao 22(6): 544-546
Makino, H.; Iraha, M.; Manba, N.; Hashidate, H.; Shiotani, M. 2012: Utility of serum human epidermal growth factor receptor-2 extracellular domain(HER2 ECD)assessment in patients with advanced or recurrent breast cancer and those who received neoadjuvant therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(2): 237-240
Schlessinger, J. 1989: Epidermal growth factor receptor proto-oncogene. Structure, evolution of properties of receptor mutants Contributions to Gynecology and Obstetrics 17: 44-48
Nizamutdinova, I.T.; Lee, G.W.; Son, K.H.; Jeon, S.J.; Kang, S.S.; Kim, Y.S.; Lee, J.H.; Seo, H.G.; Chang, K.C.; Kim, H.J. 2008: Tanshinone i effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells International Journal of Oncology 33(3): 485-491
Bigsby, R.M.; Li, A.X.; Bomalaski, J.; Stehman, F.B.; Look, K.Y.; Sutton, G.P. 1992: Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium Obstetrics and Gynecology 79(1): 95-100
He, S.W.; Guo, L.Y.; Li, J.Q. 1994: Clinical study on epidermal growth factor and its receptor in human gastric cancer Zhonghua Yi Xue Za Zhi 74(7): 413-415; 455
Madsen, M.W.; Reiter, B.E.; Larsen, S.S.; Briand, P.; Lykkesfeldt, A.E. 1997: Estrogen receptor messenger RNA splice variants are not involved in antiestrogen resistance in sublines of MCF-7 human breast cancer cells Cancer Research 57(4): 585-589
Altundag, K. 2017: Predictive markers for trastuzumab-associated cardiac dysfunction in patients with early-stage human epidermal growth factor receptor 2-positive breast cancer receiving trastuzumab Journal of BUON: Official Journal of the Balkan Union of Oncology 22(3): 801